Redefining the impact of oxygen and hyperventilation after the Norwood procedure  by Bradley, Scott M et al.
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Objective: Postoperative management after the Norwood procedure is aimed at
optimizing systemic oxygen delivery and mixed venous oxygen saturation. High
levels of fraction of inspired oxygen and hyperventilation may increase pulmonary
blood flow at the expense of systemic flow. This study determines the effects of
these interventions on mixed venous saturation and systemic oxygen delivery in
postoperative neonates.
Methods: We prospectively studied the effects of 100% fraction of inspired oxygen
and hyperventilation in 14 neonates (median age 8 days) 1 to 3 days after the
Norwood procedure, while they were sedated, paralyzed, and mechanically venti-
lated. After establishment of baseline conditions (fraction of inspired oxygen 29%
 2%, normal ventilation), patients were exposed to each of the 2 interventions in
random order. Mixed venous saturation was measured through a transthoracic line
in the superior vena cava. Oxygen excess factor (  systemic oxygen delivery/
oxygen consumption) was used as an indicator of systemic oxygen delivery.
Results: High levels of fraction of inspired oxygen produced significant increases
from baseline in systemic saturation (90%  1% vs 80%  1%, P  .01), mixed
venous saturation (54%  3% vs 44%  2%, P  .01), and oxygen excess factor
(2.6%  0.2% vs 2.3  0.2%, P  .01), but there was no change in arteriovenous
saturation difference or blood pressure. Hyperventilation resulted in no changes in
systemic or mixed venous saturation, arteriovenous saturation difference, oxygen
excess factor, or blood pressure.
Conclusions: High levels of fraction of inspired oxygen can improve mixed venous
oxygen saturation and systemic oxygen delivery after the Norwood procedure.
Hyperventilation does not change either mixed venous saturation or oxygen deliv-
ery. Management protocols aimed at minimizing the fraction of inspired oxygen and
carefully controlling ventilation may not be warranted.
The Norwood procedure is widely used to palliate neonates withhypoplastic left heart syndrome and other heart defects with afunctional single ventricle and systemic outflow tract obstruction.Operative deaths may occur in the early postoperative period in thesetting of low systemic cardiac output and oxygen delivery.1-3 Ef-forts to avoid such deaths have focused in part on limiting pulmo-
nary blood flow and improving systemic perfusion. Computer models of single
ventricle circulation have indicated that systemic oxygen delivery is maximized at
a pulmonary-to-systemic flow ratio (Qp:Qs) of approximately 1.0.4-6 Mixed venous
oxygen saturation mirrors tissue oxygen levels and peaks at a Qp:Qs near 1.0. Thus,
postoperative management after the Norwood procedure is aimed at optimizing
systemic oxygen delivery and mixed venous oxygen saturation.
Ventilatory interventions are important methods of manipulating Qp:Qs in pa-
tients with parallel pulmonary and systemic circulations.7-12 A high level of fraction
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of inspired oxygen (FIO2) and hyperventilation are 2 inter-
ventions that may potentially increase pulmonary blood
flow, possibly at the expense of decreased systemic blood
flow, systemic oxygen delivery, and mixed venous oxygen
saturation. However, little information is available on the
effects of these interventions in postoperative neonates.
This study determines the effects of high FIO2 and hyper-
ventilation on mixed venous oxygen saturation and systemic
oxygen delivery in neonates after the Norwood procedure.
Methods
Patient Demographics
This study was approved by the Institutional Review Board of the
Medical University of South Carolina, and informed consent was
obtained from all patients. Fourteen patients undergoing the Nor-
wood procedure were prospectively enrolled. Their median age
was 8 days (range 4-31 days), and their median weight was 3.0 kg
(range 2.0-4.2 kg). There were 9 boys and 5 girls. Diagnoses
included hypoplastic left heart syndrome (11 patients), double-
inlet left ventricle (2 patients), and tricuspid atresia with transpo-
sition (1 patient). Operations consisted of a standard or modified
Norwood procedure with pulmonary homograft reconstruction of
the neoaorta in all patients. All operations included a modified
Blalock-Taussig shunt (size 3.5 mm in 8 patients and 4.0 mm in 6
patients). Regional low-flow perfusion of the innominate artery
through the shunt was used in the last 8 of the 14 patients. The
mean operative support time (cardiopulmonary bypass  circula-
tory arrest) was 187  34 minutes, and the mean myocardial
ischemic time was 40  10 minutes. The mean circulatory arrest
time was 42  12 minutes in the first 6 patients and 5  1 minute
in the 8 patients with regional low-flow perfusion. Hospital sur-
vival for the study patients was 93%.
Patients were studied in the intensive care unit, while hemo-
dynamically stable, at a median of 2 days (range 1-3 days) after the
Norwood procedure. The sternum was open in 8 patients and
closed in 6 patients. During the study, patients were sedated
(fentanyl at 20 g · kg · h or morphine sulfate at 0.1 mg · kg · h
infusion), paralyzed (vecuronium 0.1 mg/kg), and mechanically
ventilated. No patient had spontaneous ventilation during the
study. All patients received dopamine at 3 to 12 g · kg · min. In
addition, 12 patients also received milrinone at 0.3 to 0.7 g · kg
· min, and 3 patients received epinephrine at 0.02 to 0.06 g · kg
· min. All infusions were maintained at constant rates, and no other
medical interventions were undertaken during the study. Mean
hematocrit was 42%  3% (range 37%-48%). All patients were in
sinus rhythm and maintained at normothermia (37°C) throughout
the study. Patients were mechanically ventilated with a Servo 300
ventilator (Siemens-Elema AB, Solna, Sweden) in pressure-regu-
lated volume control mode (6 patients) or synchronized intermit-
tent mandatory ventilation mode (8 patients). During the study,
tidal volume was 14 to 28 mL/kg, inspiratory time was 0.65 to 0.8
seconds, and positive end-expiratory pressure was 2 to 4 cm H2O;
none of these settings were altered during the study. Baseline FIO2
was adjusted to give a systemic oxygen saturation of 75% to 80%
and ranged from 0.21 to 0.5. Baseline ventilator rate was adjusted
to give a normal pH and partial pressure of carbon dioxide (PCO2).
Study Protocol
After establishment of baseline conditions, each patient was ex-
posed to the 2 interventions (high FIO2 and hyperventilation) in
random order. High FIO2 was achieved by increasing the FIO2 to
1.0, and hyperventilation was achieved by increasing the ventilator
rate. Each intervention was followed by a return to baseline con-
ditions, so that each patient was studied at 5 consecutive time
points: (1) baseline, (2) intervention 1, (3) baseline, (4) interven-
tion 2, and (5) baseline. At least 15 minutes were allowed for
stabilization at each time point before measurements were made.
Arterial blood gases and arterial pressure were determined from
umbilical or femoral arterial catheters. Systemic oxygen saturation
(SaO2) was measured by extremity pulse oximetry (Hewlett-Pack-
ard, Palo Alto, Calif) verified by co-oximetry. Common atrial
pressure was measured through transthoracic lines placed in the
operating room. Mixed venous oxygen saturation (SvO2) was de-
termined by co-oximetry from samples drawn from transthoracic
lines in the superior vena cava. These lines were placed through
the right atrial free wall into the superior vena cava, and position
was verified by postoperative chest radiograph. The following
calculations were made: arteriovenous oxygen saturation (AVO2)
difference  (SaO2  SvO2); oxygen excess factor ()5,13-15 
systemic oxygen delivery/systemic oxygen consumption  CaO2
 Qs/(CaO2 CvO2) Qs SaO2/(SaO2 SvO2), where CaO2
oxygen content of systemic arterial blood, CvO2  oxygen content
of systemic venous blood, and Qs  systemic blood flow. If
oxygen consumption remains constant, then  is directly propor-
tional to systemic oxygen delivery.5,13-15 The quantity of dissolved
oxygen (PO2  0.003) was negligible and omitted from the cal-
culation of . Pulmonary venous saturation was not measured in
our patients. Calculations of Qp:Qs were therefore deliberately
avoided because of the realization that small errors in assumed
pulmonary venous saturation result in relatively large errors in the
calculated Qp:Qs.5
Statistics
Results are shown as mean  SEM. All data were normally
distributed (Shapiro-Wilk W test) with the exception of systolic
blood pressure and mean airway pressure. Measured variables
during each intervention were compared with the average of the
preintervention and postintervention baselines by paired t test or
Wilcoxon signed rank test, as appropriate. There was no significant
effect of the order of treatment on the changes produced by the 2
interventions.
Results
High FIO2
High FIO2 was achieved by increasing the FIO2 from baseline
values to 1.0, with no change in ventilator rate or tidal
volume (Table 1). This intervention produced an increase in
mean arterial PO2 from 40 to 56 torr, but no clinically
important changes in arterial PCO2, pH, or bicarbonate level
(Table 2). High FIO2 produced significant increases from
baseline values in both SaO2 (11% 1%, P .01) and SvO2
(11% 1%, P .01) (Table 3, Figure 1). During high FIO2,
SvO2 increased in each of the 14 patients, with the increase
ranging from 4% to 17%. High FIO2 produced no change in
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AVO2 difference (0.4%  1.1%, P  .7). However, oxygen
excess factor, reflecting systemic oxygen delivery, in-
creased significantly during high FIO2 compared with base-
line (Table 3, Figure 1). Blood pressure and common atrial
pressure did not change during high FIO2 (Table 4).
There was no apparent influence of either ventricular
morphology or an open sternum on the effects of high FIO2.
Specifically, there was no difference in the changes during
high FIO2 in the 3 patients with a single left ventricle
compared with the 11 patients with hypoplastic left heart
syndrome. Similarly, there was no difference in the changes
seen in the 8 patients with an open sternum compared with
the 6 patients with a closed sternum.
Hyperventilation
Hyperventilation was achieved by increasing the ventilator
rate from a mean of 15 to 30 breaths/min while keeping the
tidal volume constant (Table 1). This increase resulted in an
increase in mean airway pressure (Table 1). Hyperventila-
tion also produced respiratory alkalosis, with a decrease in
mean PCO2 from 42 to 31 torr and an increase in mean pH
from 7.45 to 7.56 (Table 2). During hyperventilation, arte-
rial PO2 decreased from 40 to 35 torr (Table 2). However,
hyperventilation produced no changes in SaO2, SvO2, AVO2,
or oxygen excess factor (Table 3, Figure 2). Blood pressure
remained unchanged during hyperventilation, whereas there
was a small, but significant, increase in heart rate and
decrease in common atrial pressure (Table 4).
Discussion
This study shows that a high level of FIO2 can improve
mixed venous oxygen saturation and systemic oxygen de-
livery in neonates after the Norwood procedure. In contrast,
hyperventilation does not alter either mixed venous satura-
TABLE 2. Arterial blood gas values
Parameter
High FIO2 Hyperventilation
Baseline High FIO2 P Baseline Hyperventilation P
PO2 (torr) 40 1 56 2 .01 40 1 35 1 .01
PCO2 (torr) 44 1 47 2 .2 42 1 31 1 .01
pH 7.43 0.01 7.42 0.01 .02 7.45 0.01 7.56 0.01 .01
Bicarbonate (mmol/L) 28 1 28 1 .3 28 1 27 1 .01
Values are mean  SEM.
PO2, Partial pressure of oxygen; PCO2, partial pressure of carbon dioxide.
TABLE 1. Ventilator parameters
Parameter
High FIO2 Hyperventilation
Baseline High FIO2 P Baseline Hyperventilation P
FIO2 0.29 0.02 1.0 0 .01 0.29 0.01 0.29 0.01 1.0
Rate (breaths/min) 14 1 14 1 .3 15 1 30 1 .01
Tidal volume (mL) 58 2 58 2 1.0 58 2 58 2 1.0
Airway pressure (cm H2O)
Peak 24 1 24 1 .1 24 1 23 1 .03
Mean 5.4 0.2 5.5 0.2 .6 5.6 0.2 7.9 0.4 .01
Values are mean  SEM.
FIO2, Fraction of inspired oxygen.
TABLE 3. Oxygen saturation data
Variable
High FIO2 Hyperventilation
Baseline High FIO2 P Baseline Hyperventilation P
SaO2 (%) 80 1 90 1 .01 80 1 80 1 .8
SvO2 (%) 44 2 54 3 .01 42 3 42 3 .9
AVO2 difference (%) 36 2 36 2 .7 38 2 38 2 .9
Oxygen excess factor 2.3 0.2 2.6 0.2 .01 2.3 0.2 2.2 0.1 .5
Values are mean  SEM.
SaO2, Systemic oxygen saturation; SvO2, mixed venous oxygen saturation; AVO2, anteriovenous oxygen difference.
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tion or oxygen delivery. Neither high FIO2 nor hyperventi-
lation results in deleterious changes in hemodynamic pa-
rameters, including blood pressure, heart rate, and common
atrial pressure. These findings may have implications for
postoperative management strategies.
The results of the Norwood operation have improved
considerably during the last decade, partly because of the
improvement in postoperative care.16 Operative deaths may
occur in the early postoperative period in the setting of low
systemic cardiac output and oxygen delivery.1-3 Efforts to
avoid such deaths have focused in part on limiting pulmo-
nary blood flow and improving systemic perfusion. Venti-
latory interventions have been emphasized as important
methods of manipulating pulmonary vascular resistance17
and Qp:Qs.7-12 Interventions that may increase pulmonary
blood flow at the expense of systemic flow include a high
level of FIO2 and hyperventilation. These considerations
may lead to management strategies that are aimed at avoid-
ing reductions in pulmonary vascular resistance by mini-
mizing inspired oxygen and carefully controlling ventila-
tion. Although ventilatory manipulations have been studied
in several animal models of single ventricle circulation,18,19
there has been limited study of these strategies in patients.
Recent research and clinical experience have illustrated
the importance of monitoring mixed venous saturation, in
addition to systemic oxygen saturation, in patients after the
Norwood procedure. Computer models of single ventricle
circulation show that systemic oxygen delivery is maxi-
mized at a Qp:Qs of 1.0 or less.4-6 In these models, systemic
oxygen saturation by itself is an inaccurate indicator of
Qp:Qs, particularly at levels greater than 75%. Mixed ve-
nous saturation provides a more accurate measure of Qp:Qs
and oxygen delivery.4-6 Monitoring mixed venous satura-
tion in patients after the Norwood operation was first re-
ported by Rossi and colleagues in 19941 In a recent expe-
rience comprising 115 patients who underwent operations
from 1992 to 2001, venous saturation monitoring was the
only significant multivariable predictor of improved hospi-
tal survival.16 We, as well as others, have adopted postop-
erative mixed venous saturation monitoring after the Nor-
wood procedure.11,14,16,20,21 Management is aimed at
optimizing mixed venous saturation and oxygen delivery
rather than achieving a particular value of systemic satura-
tion. This study was undertaken with these management
goals in mind.
In the current study, high FIO2 increased mixed venous
saturation but not arteriovenous saturation difference. By
the Fick principle, arteriovenous saturation difference is
Figure 1. Effect of high FIO2 on oxygen saturations after the
Norwood procedure. Values are mean  SEM (*P < .01 vs
baseline).
Figure 2. Effect of hyperventilation on oxygen saturations after
the Norwood procedure. Values are mean  SEM.
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equal to the ratio of oxygen consumption to systemic blood
flow. Under the conditions of sedation and paralysis in this
study, it is unlikely that oxygen consumption changed sig-
nificantly, indicating that systemic blood flow was also
unchanged during high FIO2. This is supported by the lack of
important changes in heart rate, blood pressure, and com-
mon atrial pressure during high FIO2. Thus, the increase in
mixed venous saturation seemed to be the result of an
increase in systemic saturation in the setting of preserved
systemic blood flow.
High FIO2 may have increased systemic saturation by
increasing either pulmonary venous saturation or pulmonary
blood flow. After the Norwood procedure, pulmonary ve-
nous saturation is not generally measured and is often
assumed to be normal (96%). However, a recent study of
12 patients within 3 days of the Norwood procedure found
that pulmonary venous desaturation occurred frequently.21
Pulmonary venous saturations less than 95% were observed
in 11 of 12 patients, in the absence of radiographic evidence
of pulmonary disease, and could occur with an FIO2 greater
than 30%. On the basis of this information, it is likely that
many of our study patients had pulmonary venous desatu-
ration at baseline, when their mean FIO2 was 0.29. High FIO2
may then have increased systemic oxygen saturation be-
cause of an increase in pulmonary venous saturation.
High FIO2 may have also increased systemic saturation
by increasing pulmonary blood flow. Oxygen is a known
pulmonary vasodilator and could have increased pulmonary
flow by decreasing pulmonary vascular resistance. Any
increase in pulmonary flow seems to have been accompa-
nied by an increase in overall cardiac output so that “pul-
monary overcirculation” with decreased systemic flow,
blood pressure, and oxygen delivery did not result. To the
extent that total cardiac output increases during high FIO2,
this would constitute a volume load on the single ventricle.
However, we speculate that any increase in pulmonary flow
caused by increasing FIO2 was limited by the fixed resis-
tance of the modified Blalock-Taussig shunt.
In this study, the oxygen excess factor was used as an
indicator of systemic oxygen delivery. Oxygen excess fac-
tor is defined as the ratio of systemic oxygen delivery to
oxygen consumption and is calculated as SaO2/SaO2 
SvO2.5,13,14 If oxygen consumption remains constant, the
oxygen excess factor is directly proportional to systemic
oxygen delivery.5 The oxygen excess factor has been used
as a measure of oxygen delivery in a previous computer
model of single ventricle circulation5 and studies of patients
before and after the Norwood procedure.14,15 Under the
conditions of sedation and paralysis in this study, it is likely
that oxygen consumption changed little and that oxygen
excess factor provided a reasonable index of systemic ox-
ygen delivery. More direct methods of measuring oxygen
delivery in postoperative patients would clearly be valuable.
Under the conditions of this study, hyperventilation had
no significant effect, either positive or negative, on oxygen
saturations or hemodynamic values. The decrease in arterial
PO2, despite no change in systemic oxygen saturation (Table
2), was likely because of the leftward shift in the oxyhe-
moglobin dissociation curve that results from decreasing
PCO2 and increasing pH. Alkalosis has been shown to de-
crease pulmonary vascular resistance in both children and
adults after cardiopulmonary bypass.17,22,23 As a conse-
quence, hyperventilation is considered a management op-
tion to improve systemic oxygen saturation in patients with
low pulmonary blood flow after the Norwood proce-
dure.10,11 The failure of hyperventilation to alter systemic
saturation in our study patients may have been because of
the fixed resistance provided by the systemic-to-pulmonary
shunt or the low baseline resistance in the pulmonary vas-
cular bed distal to the shunt. Alternatively, any reduction in
pulmonary resistance effected by hyperventilation may have
been offset by the accompanying increase in mean airway
pressure (Table 1).
The lack of effect of hyperventilation contrasts with the
results of 2 previous studies. The first examined the effects
of hyperventilation in patients after a bidirectional superior
cavopulmonary connection.24 In that study, hyperventila-
tion produced a significant increase in the arteriovenous
oxygen saturation difference across the upper body. This
seemed to be caused by a decrease in cerebral blood flow, as
indicated by transcranial Doppler sonography.24 In the cur-
rent study, cerebral blood flow was not examined, but
TABLE 4. Hemodynamic variables
Variable
High FIO2 Hyperventilation
Baseline High FIO2 P Baseline Hyperventilation P
Heart rate (beats/min) 161 4 159 4 .02 160 4 165 4 .01
Blood pressure (mm Hg)
Mean 52 1 52 2 .7 51 1 50 1 .3
Systolic 75 2 77 3 .4 74 2 72 2 .2
Diastolic 36 1 37 1 .8 36 1 35 1 .2
Common atrial pressure (mm Hg) 6.8 0.4 6.8 0.4 1.0 6.9 0.4 6.1 0.4 .01
Values are mean  SEM.
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hyperventilation did not produce a change in arteriovenous
saturation difference. It is possible that differences in patient
age, cerebral venous pressure, or source of pulmonary blood
flow account for the differing response to hyperventilation
in these 2 studies. The second previous study examined the
effects of inspired CO2 in infants after the Norwood proce-
dure.20 In that study, respiratory acidosis, produced by
adding 3% CO2 to the inspired gas mixture, produced an
increase in mixed venous saturation and a decrease in arte-
riovenous oxygen saturation difference.20 In the current
study, respiratory alkalosis, produced by hyperventilation,
produced no changes in oxygen saturations. These contrast-
ing results may be explained by the increase in mean airway
pressure during hyperventilation. After the Norwood proce-
dure, inspired CO2 may be a more effective means of ma-
nipulating oxygen delivery than hyperventilation.
The results of this study indicate that efforts to minimize
FIO2 and carefully control ventilation in the patient after the
Norwood procedure may not be warranted. This is consis-
tent with a previous report showing that hemodynamic
stability and good clinical outcome can result despite a
relatively high FIO2 and alkalosis in the early postoperative
period.25 Increasing FIO2 from the low levels frequently
used in clinical practice may be a useful approach to im-
prove oxygen delivery. This study, as well as others, dem-
onstrated that mixed venous oxygen saturation has a nadir 6
to 12 hours after the Norwood operation.1,26 Patients with
mixed venous saturation less than 30% are at risk for
anaerobic metabolism.27 Such patients might derive clinical
benefit from even a relatively modest increase in oxygen
delivery. In our current management strategy, the effect of
FIO2 on mixed venous saturation is used to determine the
optimal FIO2 in a given patient.
This study has several limitations. A small number of
patients were studied in the early postoperative period under
conditions of sedation and paralysis. The potential advan-
tages or disadvantages of the study interventions under
other conditions would be speculative. Each intervention
was applied for a short period of time, and only 1 level of
high FIO2 was studied to limit the total time of the study. All
mixed venous blood samples were drawn from the superior
vena cava, which may not reflect true mixed venous satu-
ration. Finally, pulmonary and systemic blood flows, and
pulmonary vascular resistance were not directly measured,
because this is not generally possible in newborns after the
Norwood procedure.
Conclusion
This study found that high FIO2 can improve mixed venous
oxygen saturation and systemic oxygen delivery in neonates
after the Norwood procedure. In contrast, hyperventilation
does not change either mixed venous saturation or oxygen
delivery. Under the conditions studied, neither intervention
seemed to increase pulmonary blood flow at the expense of
decreased systemic blood flow, blood pressure, and oxygen
delivery. Increasing FIO2 may be a useful intervention in
some patients with low systemic oxygen delivery after
operation. These findings support the ongoing investigation
of methods to maximize oxygen delivery to further improve
the outcome of the Norwood procedure.
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Discussion
Dr James S. Tweddell (Milwaukee, Wis). Dr Bradley, I con-
gratulate you on an outstanding presentation that adds to our
understanding of the management of patients after stage 1 pallia-
tion of hypoplastic left heart syndrome.
This type of systematic analysis of postoperative management
strategies is critical if we are to improve outcomes both in terms of
early mortality and long-term morbidity, particularly in neurode-
velopmental outcome.
Francis and colleagues from the Royal Brompton Hospital
stated it well when they said that for any given arterial oxygen
content, an increase in systemic output would be clearly beneficial.
I think the corollary of that statement, that for any given
systemic output, an increase in arterial oxygen content would
clearly be beneficial, is equally correct. This much is not in
contention.
You have demonstrated that, at least acutely, the use of a higher
FIO2 results in improved systemic oxygen delivery. Your findings
also indicate that at least in the acute setting, increasing arterial
saturation correlates positively with increasing systemic venous
saturation.
Therefore, an elevated arterial saturation in the postoperative
hypoplast is not a harbinger of impending doom, but may reflect
excellent cardiac output and systemic oxygen delivery.
Indeed, the management strategy unique to this set of patients,
which is actually to increase their level of cyanosis, is one still
commonly used and with little objective data to justify it.
This study demonstrates practically and irrefutably the benefits
and even the necessity of objective assessment of systemic oxygen
delivery using continuous venous saturation monitoring.
Using our current management strategies, we also noted a
positive correlation between arterial and venous saturation in the
same group of patients. This slide reflects approximately 2500
patient hours of data and correlates the arterial saturation and
venous saturation of those patients receiving the current manage-
ment strategy using phenoxybenzamine. I think you can see clearly
a very strong positive correlation between arterial and venous
saturation over a wide range.
As a consequence, our management strategy does not call for
tight control of arterial saturation using ventilatory manipulations
or medical gas management. We commonly use an FIO2 of 40%.
Instead, we target the venous saturation, as you have done, as an
indicator of a satisfactory postoperative course.
How have these findings changed your postoperative manage-
ment? For this study, you did indeed target an arterial saturation of
80%. Have you abandoned a strategy of limiting arterial saturation
during the postoperative period?
During the postgraduate course, you showed us some very
interesting data regarding your experience with the Sano modifi-
cation of stage 1 palliation. It has been suggested that this modi-
fication diminishes the need for complex ventilator management.
On the basis of your experience with the RV-PA conduit, can
you provide us with any objective data to support those claims?
Interestingly, you did not identify an impact of hyperventilation
on systemic oxygen delivery, yet your previous studies indicate
that the addition of CO2 to the inspired gas mixture of patients
after the Norwood procedure did in fact result in a reduction of the
Qp:Qs. I wonder whether you have considered repeating this
portion of the study controlling for mean airway pressure to see
whether hypocapnia does indeed result in elevation of pulmonary
to systemic flow ratio.
Dr Bradley. Thank you for your comments. Certainly many of
them reinforce our results. It is particularly interesting that you
observed a positive correlation between systemic and mixed ve-
nous saturations in your patients receiving phenoxybenzamine and
that we observed the same in patients not receiving phenoxyben-
zamine.
We began monitoring mixed venous saturation in late 1996.
Since that time, our postoperative management has not been aimed
at targeting a particular arterial saturation or limiting arterial
saturation, rather it has been aimed at optimizing mixed venous
saturation. For the baseline in this study, we selected an arterial
saturation of 75% to 80%, but that is not generally the approach of
our postoperative management.
In terms of the Sano modification, the information I showed
yesterday was quite preliminary, being based on only 10 patients.
It showed that the mixed venous saturations in the patients with an
RV-to-PA shunt were very similar to those in the patients with a
modified Blalock-Taussig shunt during the first 24 hours. At this
point, I really do not know whether ventilatory manipulations will
be any more or less important with the Sano modification than with
the modified Blalock-Taussig shunt.
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We were also interested in the lack of effect produced by
hyperventilation, given our previous results with inspired carbon
dioxide. I would be cautious in making conclusions about Qp/Qs.
Qp/Qs calculations, as everyone is aware, depend on the level of
pulmonary venous saturation. Although we may frequently assume
these are normal in patients after the Norwood procedure, an
important study from the Cincinnati group showed that even in the
presence of a clear chest x-ray film (in the 1- to 3-day postoper-
ative period), pulmonary venous saturations are often decreased
and that these decreases can result in fairly large errors in calcu-
lated Qp/Qs. So we have avoided assumed calculations of Qp:Qs.
What we did show in our previous study was that inspired carbon
dioxide increased mixed venous saturation, which was directly
measured. A decrease in Qp/Qs may have been one explanation.
Another may have been that CO2 is a systemic vasodilator, and
you have been a leader in teaching us that systemic vasodilation
may be useful after the Norwood procedure. As you suggest, the
increase in mean airway pressure during hyperventilation may
have negated any effects of hypocapnia, which would be interest-
ing to look at in the future.
Dr Peter B. Manning (Cincinnati, Ohio). Scott, because we
looked at a very similar population and collected a very similar
data set, and the one additional piece of information we measured
was the pulmonary venous saturations, I can confirm your specu-
lation that pulmonary venous desaturation may in fact be playing
a part. In 30% of the samples in our study, there was pulmonary
venous desaturation, and our study was a little different in that we
varied the FIO2 from 17% to as high as 50%.
Even when the FIO2 was 30%, which was the level you were
ventilating the kids with, we still saw some individual data points
in which there was pulmonary venous desaturation.
We could always correct that by pushing the FIO2 up to 50%. I
would be interested, although you presented the data at just 100%,
if you had other data as far as when you get that correction below
100%, as we saw.
The other thing we noticed was that if we pushed the peak
end-expiratory pressure up quite often, we could get rid of the
pulmonary venous desaturation without necessarily changing the
FIO2. We may be correcting some V/Q mismatch, and I was
curious what tidal volumes and levels of peak end-expiratory
pressure you used.
I thought it was an excellent study.
Dr Bradley. Thank you, Peter. I do appreciate your study. I
think it was very important in showing us that pulmonary venous
desaturation can be very common and that our Qp/Qs calculations
may not be accurate.
We did not do any oxygen titration, as you did, so I can’t
comment on the optimal level of oxygen. We picked 1 level of FIO2
for this study to limit the time period. In clinical management, I
think it would be useful to titrate the oxygen, follow the mixed
venous saturation, and pick the optimal FIO2 on that basis.
In general, our patients were ventilated with peak end-expira-
tory pressure  3 cm of water, tidal volumes of approximately 20
mL/kg, and peak airway pressures that ended up being in the low
20s. None of these were altered during this study.
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